Antitubercular agent-17
RSD-921
N-type calcium channel blocker-1
MFZ 10-7
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole
Dimethoate
Avermectin B1
D-AP7
Fludalanine
4-Acetamidobutanoic acid
Homocarnosine acetate
(E)-GABAB receptor antagonist 1
6,2'-Dihydroxyflavone
Lesogaberan
SCH 50911
Bamaluzole
Isotanshinone I
Radequinil
Ramelteon metabolite M-II
KL001
Prolylleucine
KL044
(±)12-HEPE
NO-Indomethacin
PW0464
Protectin D1
Ajmalicine
RVX-297
Simufilam dihydrochloride
BMS-520
α-Cyclodextrin
AH 001
Vazegepant
Telcagepant
Atogepant
Dexamethasone cipecilate
α-CGRP(human)
HTS01037
BMS-309403 sodium
AAK1-IN-3
AAK1-IN-4
AAK1-IN-5
δ14-Triamcinolone acetonide
N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid
JKC363
CM398
SGC-GAK-1
BMT-090605 hydrochloride
Vortioxetine D8
(3R,5S)-Fluvastatin
(3S,5R)-Fluvastatin D6 sodium
Imiloxan
LY2940094 tartrate
(S)-Venlafaxine
5-Methoxyindole-3-acetic acid
L-Glutathione,oxidized(sodium salt)
D159687
2-(Isopentylamino)naphthalene-1,4-dione
BIBO3304
BW 723C86 hydrochloride
